Zhao Robert Chunhua, Zhu Ya-Shu, Shi Yufang
Institute of Basic Medical Sciences & School of Basic Medicine, Center of Excellence in Tissue Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, 5# Dongdansantiao, Beijing, 100005, PR China.
Pharmacol Ther. 2008 Jul;119(1):74-82. doi: 10.1016/j.pharmthera.2008.04.008. Epub 2008 May 20.
For decades, intensive studies have attempted to identify the mechanisms underlying malignant tumor growth. Despite significant progress, most therapeutic approaches fail to eliminate all tumor cells. The remaining tumor cells often result in recurrence and metastasis. Recently, the idea of a cancer stem cell was proposed to explain of the origin of cancer cells. According to this hypothesis, a small fraction of tumor cells have the capacity for self-renewal, with unlimited slow proliferation potential. They are often resistant to chemotherapy and radiation and thus are responsible for continuously supplying new cancer cells, which themselves may have a limited life span. In recent years, accumulating experimental evidence supports this hypothesis and provides new possibilities to conquer cancer. This review will focus on the distinction between normal adult stem cells and cancer stem cells and identifies possible key targets for effective therapies of cancer.
几十年来,深入研究一直试图确定恶性肿瘤生长的潜在机制。尽管取得了重大进展,但大多数治疗方法都无法消除所有肿瘤细胞。残留的肿瘤细胞常常导致复发和转移。最近,有人提出癌症干细胞的概念来解释癌细胞的起源。根据这一假说,一小部分肿瘤细胞具有自我更新能力,拥有无限缓慢增殖的潜力。它们通常对化疗和放疗具有抗性,因此负责持续供应新的癌细胞,而这些癌细胞自身的寿命可能有限。近年来,越来越多的实验证据支持这一假说,并为攻克癌症提供了新的可能性。本综述将聚焦于正常成体干细胞与癌症干细胞之间的区别,并确定癌症有效治疗的可能关键靶点。